Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc.

20.00
EUR
-0.60
(-2.91%)
-3.51EPS
1.88BMarket Cap
Nov 04Next Earn

Latest Stock Split

Nov 13, 2020

1:15

For every 15 shares held, investors received 1.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Nov 13, 2020
    Before—
    Split ratio1:15
    After—
    Reverse
  2. Nov 07, 2016
    Before—
    Split ratio1:15
    After—
    Reverse

About Viridian Therapeutics, Inc. stock splits

Viridian Therapeutics, Inc. (GETTEX:1S1) operates in the Pharmaceuticals: major industry.

Viridian Therapeutics, Inc. company overview

When did Viridian Therapeutics, Inc. stock split?

Viridian Therapeutics, Inc.'s most recent stock split was on November 13, 2020. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.

What is Viridian Therapeutics, Inc.'s stock split history?

Viridian Therapeutics, Inc. (GETTEX:1S1) has split its stock 2 times: a 1-for-15 reverse split on November 7, 2016 and a 1-for-15 reverse split on November 13, 2020.

How many times has Viridian Therapeutics, Inc. stock split?

Viridian Therapeutics, Inc. has split its stock 2 times. This history records 2 reverse splits between November 7, 2016 and November 13, 2020.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Viridian Therapeutics, Inc.'s 1-for-15 reverse split on November 13, 2020, every 15 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will Viridian Therapeutics, Inc. split its stock again?

Viridian Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on November 13, 2020, 5 years ago. Companies announce splits in advance, and any new GETTEX:1S1 split will appear on this page.